Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge

NCT ID: NCT03223584

Last Updated: 2018-02-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-11-30

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Title of the research:

Exploratory study to inventory opportunities to optimize continuity of pharmacotherapy at hospital discharge

Study area:

Care region Leuven (individual interviews), care region Bruges (individual interviews) and care region Mortsel (One focus group).

Aims:

From an explorative angle, the study aims to identify hurdles, barriers, facilitators and needs that general practitioners and community pharmacists experience with patients who have recently been discharged from a hospital. From a feasibility standpoint, the study aims to investigate what supportive actions are feasible and useful to optimize the care process upon hospital discharge. For this purpose, a discharge document for the community pharmacist will be shown to the healthcare professionals. The HCP will be given the opportunity to give feedback on this document.

Study design:

A non-interventional, qualitative study is set up using face-to-face, semi-structured interviews and a focus group.

Study population:

Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders.

Number of health care professionals:

Individual interviews will be organised until there is saturation of information and no new elements are provided in the interviews. At least five community pharmacists and five general practitioners will be interviewed per care region. In addition, a focus group will take place in care region Mortsel.

Procedures:

Upon an informed consent of the healthcare professional, a semi-structured face-to-face interview will take place. The interview will focus on concrete patient cases, provided by the healthcare professional, as well as a fictional case of the researcher. In the focus group, data of the individual interviews will be presented and the relevance and completeness of the information will be assessed. Finally, the aim of the focus group is to reach a consensus on the research questions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pharmacist Physicians, Primary Care Patient Discharge

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pharmacists-Leuven

Individual interviews with approximately 5 pharmacists

No interventions assigned to this group

Pharmacists-Bruges

Individual interviews with approximately 5 pharmacists

No interventions assigned to this group

Pharmacists-Mortsel

A focus group with pharmacists and general practitioners

No interventions assigned to this group

General Practitioners-Leuven

Individual interviews with approximately 5 general practitioners

No interventions assigned to this group

General Practitioners-Bruges

Individual interviews with approximately 5 general practitioners

No interventions assigned to this group

General Practitioners-Mortsel

A focus group with pharmacists and general practitioners

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Profession: general practitioner or community pharmacists
* Employment in care regions Leuven, Bruges or Kontich
* Experience in daily practice
* Interest in research or optimisation of the healthcare profession. For example supervisors of an internship, local coordinators of general practitioners or pharmacy clusters and active HCP that are linked with professional associations.

Exclusion Criteria

None
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

KU Leuven

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Joke Wuyts

PharmD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KU Leuven

Leuven, Vlaams-Brabant, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

References

Explore related publications, articles, or registry entries linked to this study.

Wuyts J, Vande Ginste M, De Lepeleire J, Foulon V. Discharge report for the community pharmacist: Development and validation of a prototype. Res Social Adm Pharm. 2020 Feb;16(2):168-177. doi: 10.1016/j.sapharm.2019.04.049. Epub 2019 Apr 25.

Reference Type DERIVED
PMID: 31078447 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S58480

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Switch Timely to Oral Medication
NCT03254407 COMPLETED NA